Form 4: CVS Executive Prem Shah Sells Shares for Tax Obligations

CVS Health EVP Prem S. Shah disposed of 6,995 shares of common stock to cover tax withholdings from a restricted stock unit award.

Summary

• Prem S. Shah, Executive Vice President and Group President of CVS Health Corp, reported a transaction involving the company's common stock.
• The transaction, dated August 31, 2025, involved the disposition of 6,995 shares of CVS Common Stock.
• The shares were surrendered at a price of $73.15 per share to satisfy withholding taxes due upon the vesting and settlement of a restricted stock unit award.
• Following this transaction, Prem S. Shah directly beneficially owns 60,631.677 shares of CVS Common Stock.

Sentiment

Score: 5

Explanation: The transaction is a routine tax-related disposition of shares by an executive upon the vesting of restricted stock units, which is a common and expected event and does not reflect a change in company fundamentals or executive sentiment towards the company's future.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or outlook.

Management Comments

• The surrender of shares was in payment of withholding taxes due upon the vesting and settlement of a restricted stock unit award.

Industry Context

This transaction is a routine insider filing, common across all industries, where executives dispose of a portion of their equity compensation to cover tax obligations upon vesting. It does not reflect a discretionary sale based on market sentiment or company performance.

Comparison to Industry Standards

• The practice of surrendering shares to cover tax liabilities upon the vesting of restricted stock units is a standard and widely accepted mechanism for equity compensation in publicly traded companies across various sectors, including healthcare and retail pharmacy, similar to practices at companies like Walgreens Boots Alliance or UnitedHealth Group.

Stakeholder Impact

• Shareholders: Minimal impact as this is a routine, non-discretionary transaction for tax purposes, not indicative of a change in executive confidence or company fundamentals.

Key Dates

Recommendation

This Form 4 reports a routine, non-discretionary sale of shares by an executive to cover tax obligations upon the vesting of restricted stock units. It does not indicate a change in the company's fundamentals or the executive's long-term view, and therefore, does not warrant a change in investment recommendation based solely on this filing.

Keywords

CVS Health, Prem S. Shah, Insider Transaction, Form 4, Stock Sale, Restricted Stock Unit, Tax Withholding